Cargando…
Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line
Among patients with the rare diagnosis of pancreatic neuroendocrine tumor (P-NET), a substantial proportion suffer from the inherited cancer syndrome multiple endocrine neoplasia type 1 (MEN1), which is caused by germline mutations of the MEN1 suppressor gene. Somatic mutations and loss of the MEN1...
Autores principales: | Monazzam, Azita, Li, Su-Chen, Wargelius, Hanna, Razmara, Masoud, Bajic, Duska, Mi, Jia, Bergquist, Jonas, Crona, Joakim, Skogseid, Britt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471701/ https://www.ncbi.nlm.nih.gov/pubmed/32884006 http://dx.doi.org/10.1038/s41598-020-71516-7 |
Ejemplares similares
-
Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration
por: Razmara, Masoud, et al.
Publicado: (2018) -
MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines
por: Li, Su-Chen, et al.
Publicado: (2021) -
Increased Expression of GLP-1R in Proliferating Islets of Men1 Mice is Detectable by [(68)Ga]Ga-DO3A-VS-Cys(40)-Exendin-4 /PET
por: Monazzam, Azita, et al.
Publicado: (2018) -
Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors
por: Mollazadegan, Kazhan, et al.
Publicado: (2022) -
Bon-Bons
Publicado: (1906)